Igene Biotechnology Operating Income

Igene Biotechnology (IGNE) currently reports a operating income of $-2.3M as of September 2010. That compares with $-1.9M in the prior-year period — down 20.0% year over year. Use the charts on this page to explore Igene Biotechnology's operating income history and peer comparisons.

Igene Biotechnology's operating income decreased from $-1.9M to $-2.3M — a 20.0% year-over-year decrease (period ending September 2010). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Igene Biotechnology reported $-2.3M in operating income as of September 2010. That compares with $-1.9M in the prior-year period — down 20.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-2.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Igene Biotechnology, and consider following IGNE for alerts when major investors trade the stock.